Our Promise to You

Guaranteed product quality, expert customer support

Our Promise to You

OCI-AML-5

  • Specification
  • Recommended Products
Cat.No.
CSC-6982J
Description
Established from the peripheral blood of a 77-year-old man with acute myeloid leukemia (AML M4) in relapse in 1990
Species
Homo sapiens (human)
Tissue of Origin
Peripheral blood
Source
Peripheral blood
Recommended Medium
80-90% alpha-MEM (with ribo- and deoxyribonucleosides) + 10-20% h.i. FBS + 10 ng/ml GM-CSF
Culture Properties
Suspension
Morphology
Small, round cells growing singly or in clumps in suspension
Storage
Liuqid Nitrogen, -180°C
Shipping
Dry ice
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.
CSC-6249W
CSC-6280W
CSC-6281W
CSC-6282W
CSC-6296W
CSC-6308W

For research use only. Not for any other purpose.

  • Background
  • Scientific Data
  • Q & A
  • Customer Review
  • Product Information Sheet

OCI-AML-5 cells are a well-known cell line that was established in 1990 from the peripheral blood of a 77-year-old man diagnosed with acute myeloid leukemia (AML) of French-American-British (FAB) subtype M4 at the time of relapse. These cells have been extensively used in research studies focused on understanding the molecular and cellular characteristics of AML, as well as in drug discovery and therapeutic development efforts.

The establishment of OCI-AML-5 cells from a relapsed AML patient is particularly significant as it allows researchers to study the behavior and genetic alterations specific to AML cells during disease progression and after treatment. This provides valuable insights into the mechanisms underlying AML relapse, drug resistance, and disease evolution.

An Image-Based Flow Cytometric Approach to Assess N: C Ratio of OCI-AML-5 Cell Lines

The nucleus-to-cytoplasm ratio (N: C) can be used as one metric in histology for grading certain types of tumor malignancy. OCI-AML-5, a blood cancer cell line, was interrogated by an image-based flow cytometer (IFC). Initially, 43,237 OCI-AML-5 cells were imaged using the IFC within minutes. In the IFC gating process, out-of-focus cells, cell images containing alignment beads, and multiple or fragmented cells were excluded. Objects analyzed in the IDEAS software indicated a larger nucleus mask than a cytoplasm mask. From this post-processing, 5284 OCI-AML-5 cells were able to be analyzed (Fig. 1).

Table 1 shows that the diameter of OCI-AML-5 cells (12.3 ± 1.2 μm) is consistent with previously published values obtained using the Coulter Counter. The nuclear diameter of these cells follows a similar trend, with OCI-AML-5 cells measuring 9.0 ± 1.1 μm. Based on these measurements, the N: C ratio was calculated for each cell line. The N: C ratio for OCI-AML-5 cells was 0.73 ± 0.07.

IFC analysis workflow and representative cells.Fig. 1 IFC analysis workflow and representative cells. (Sebastian JA, et al., 2021)

Table 1. A summary of IFC measurements and corresponding standard deviations for the cell and nucleus diameter as well as the N: C ratio for the OCI-AML-5 cell line. (Sebastian JA, et al., 2021)

Cell lineOCI-AML-5 (n=5284)
Cell diameter (μm)12.3 ± 1.2
Nucleus diameter (μm)9.0 ± 1.1
N: C0.73 ± 0.07
Q:
What are the 4 types of leukemia?
A:

Acute lymphocytic leukemia is the most common kind of leukemia. Acute myelogenous leukemia is the most common kind of aggressive leukemia in adults. Chronic lymphocytic leukemia is the most common type of slow-growing leukemia. Chronic myelogenous leukemia usually affects adults.

Q:
What are the characteristics of OCI-AML-5 cells?
A:

OCI-AML-5 cells exhibit abnormal proliferation, impaired differentiation, and the ability to form colonies in vitro, which are typical characteristics of AML cells.

Q:
How have OCI-AML-5 cells contributed to AML research?
A:

OCI-AML-5 cells have been extensively used in research studies to investigate the genetic and molecular alterations associated with AML. They have provided valuable insights into disease progression, drug resistance, and the identification of potential therapeutic targets.

Q:
Can OCI-AML-5 cells be used for drug screening?
A:

Yes, OCI-AML-5 cells are commonly used in drug screening assays to evaluate the efficacy and mechanisms of action of various therapeutic agents. They help researchers assess the potential effectiveness of drugs and facilitate the development of new treatment approaches for AML.

Ask a Question

Average Rating: 5.0    |    3 Scientist has reviewed this product

Reasonable price

The price of the product is reasonable for the quality of the cells.

05 Feb 2022


Ease of use

After sales services

Value for money


In good condition

The cells arrived in good condition and were accompanied by comprehensive documentation, including a certificate of analysis and handling instructions.

01 Feb 2024


Ease of use

After sales services

Value for money


Satisfied

I recently purchased the OCI-AML-5 cell line from Creative Bioarray and have been pleased with the product overall.

14 Nov 2023


Ease of use

After sales services

Value for money


Write your own review

Customer Support & Price Inquiry

Verification Code